CYTK — CYTOKINETICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 510 家机构在其最新 13F 申报中持有 CYTK(CYTOKINETICS INC),合计申报市值 $11.71B,对应 212.27M 股。按股数计算较上季度增持 19.9%(+32.65M 股),申报市值环比上升 55.9%。持仓集中度较高:前五大持有人占申报市值的 41.2%,前十大的集中度为 51.8%。
与上一季度相比,91 家新建仓位、246 家加仓、107 家减仓、53 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
CYTOKINETICS INC(CYTK)的主要机构持有人包括 Shaolin Capital Management LLC、Taconic Capital Advisors LP、T. Rowe Price Investment Management, Inc.,按 13F 申报市值在本页 844 家持有人中排名居前。
CYTK 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 353 | 108.60M | $4.86B | +3.2% |
| Q2 2026 | 510 | 212.27M | $11.71B | +19.9% |
| Q1 2026 | 470 | 174.81M | $7.61B | -28.9% |
| Q4 2025 | 451 | 228.68M | $6.91B | -0.2% |
| Q3 2025 | 398 | 217.34M | $6.20B | +10.2% |
| Q2 2025 | 335 | 282.54M | $3.04B | +3.2% |
| Q1 2025 | 370 | 282.49M | $5.16B | -3.6% |
| Q4 2024 | 361 | 262.70M | $3.94B | -5.3% |
表内 8 个季度中,机构持股合计减少 59%(Q4 2024 → Q3 2026);单季变动最大的是 Q1 2026(-28.9%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 3.71M 股 · $316.33M
- Sixth Street Partners Management Company, L.P. 1.57M 股 · $133.39M
- Holocene Advisors, LP 1.14M 股 · $97.51M
- Hood River Capital Management LLC 469.27K 股 · $39.98M
- Polaris Capital Management, LLC 266.90K 股 · $22.74M
- Jupiter Topco LLC 244.42K 股 · $20.82M
- BAKER BROS. ADVISORS LP 211.27K 股 · $18.00M
- Tri Locum Partners LP 194.00K 股 · $16.53M
- PFM Health Sciences, LP 191.69K 股 · $16.33M
- Ghisallo Capital Management LLC 170.00K 股 · $14.48M
- KINGDON CAPITAL MANAGEMENT, L.L.C. 157.10K 股 · $13.38M
- Polymer Capital Management (HK) LTD 138.25K 股 · $11.78M
完全清仓(较上季)
- STATE STREET CORP 卖出 5.75M 股 · $378.67M
- Paradigm Biocapital Advisors LP 卖出 1.48M 股 · $97.60M
- Logos Global Management LP 卖出 875.00K 股 · $57.67M
- MPM BioImpact LLC 卖出 500.00K 股 · $32.95M
- Vestal Point Capital, LP 卖出 300.00K 股 · $19.77M
- Ikarian Capital, LLC 卖出 283.57K 股 · $18.69M
- Janus Henderson Group 卖出 282.12K 股 · $18.59M
- Catalio Capital Management, LP 卖出 215.50K 股 · $14.20M
- Monashee Investment Management LLC 卖出 100.00K 股 · $6.59M
- Troluce Capital Advisors LLC 卖出 100.00K 股 · $6.59M
- Sofinnova Investments, Inc. 卖出 91.79K 股 · $6.05M
- SILVERARC CAPITAL MANAGEMENT, LLC 卖出 71.20K 股 · $4.69M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 21.04M | 20.09M | 16.55M | 16.40M | 15.53M | 5.38M | 5.58M | 4.88M | 4.28M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.80M | 6.71M | 5.84M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.27M | 6.12M | 5.49M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 3.77M | 3.71M | 3.22M | 3.06M | 3.04M | 2.99M | 2.94M | 2.84M | 2.85M | 2.74M | 2.25M | 2.09M | 1.98M | 1.91M | 1.73M | 1.66M | 1.59M | 1.48M | 1.47M | 1.43M |
| Invesco Ltd | 3.02M | 1.24M | 484.98K | 204.88K | 157.25K | 136.31K | 501.88K | 1.00M | 1.00M | 1.10M | 1.32M | 1.24M | 1.18M | 1.50M | 1.48M | 1.45M | 1.41M | 547.60K | 398.65K | 759.67K |
| Capital Research Global Investors | 2.45M | 1.69M | 771.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.58M | 1.60M | 1.09M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 1.37M | 1.16M | 750.95K | 757.56K | 1.15M | 1.55M | 1.96M | 1.91M | 2.09M | 1.77M | 1.75M | 1.37M | 2.25M | — | — | — | — | — | — | — |
| Principal Global Investors | 1.23M | 1.31M | 1.09M | 976.89K | 1.17M | 1.18M | 629.91K | 271.13K | 273.08K | 393.58K | 431.56K | 521.17K | 525.28K | 555.72K | 582.90K | 665.38K | 612.45K | 673.27K | 658.15K | 677.12K |
| BNY Mellon | 1.17M | 200.00K | 200.00K | 200.00K | 300.00K | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K | 400.00K | 400.00K | 1.29M | 1.28M | 1.32M | 1.37M | 1.14M | 840.69K | 881.17K |
| GW&K Investment Management, LLC | 1.02M | 916.11K | 494.62K | 472.36K | 180.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Royalty Pharma Sub-Manager, LLC | 980.39K | 980.39K | 980.39K | 980.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 944.84K | 1.17M | 24.90K | 1.13M | 19.80K | 3.07M | 581.00K | 1.20M | 600 | 299.60K | 298.74K | 12.80K | 91.30K | 318.10K | 266.93K | 335.22K | 210.90K | 164.48K | 248.02K | 244.37K |
| VANGUARD FIDUCIARY TRUST CO | 930.36K | 906.42K | 799.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WCM INVESTMENT MANAGEMENT, LLC | 910.49K | — | — | — | — | — | — | — | 71.79K | 76.81K | 43.87K | — | — | — | — | — | — | — | — | — |
| Fisher Asset Management, LLC | 818.83K | 743.70K | 768.26K | 822.88K | 761.59K | 733.68K | 793.46K | 616.49K | 542.28K | 534.52K | 538.80K | 536.05K | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 750.00K | 550.00K | 700.48K | 800.00K | 350.00K | — | — | — | — | — | 80.00K | 160.00K | 230.37K | — | — | — | — | — | — | — |
| Siren, L.L.C. | 708.95K | 758.95K | 613.95K | — | — | — | — | 402.32K | 525.97K | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 706.18K | 689.08K | 854.37K | 579.86K | 247.47K | 290.25K | 237.60K | 24.65K | 40.29K | 55.92K | 171.55K | 198.89K | 102.81K | — | — | — | — | — | — | — |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | 661.16K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold CYTK?
As of 2026-Q2, 510 institutional funds reported holding CYTK (CYTOKINETICS INC) in SEC 13F filings, with a combined reported value of $11.71B.
How many shares of CYTK do institutions own?
13F filers reported 212.27M shares of CYTK, worth $11.71B in aggregate at the end of 2026-Q2.
Is institutional ownership of CYTK rising or falling?
Share counts moved +19.9% versus the prior quarter — accumulation.
Who are the top institutional holders of CYTK?
The largest 13F holders are Shaolin Capital Management LLC, Taconic Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of CYTOKINETICS INC?
The major shareholders of CYTOKINETICS INC (CYTK) by reported 13F value are Shaolin Capital Management LLC, Taconic Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc, Vanguard Group, among 844 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.